ema tirzepatide Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 26-29 January 2026 Meeting highlights from the Committee

GLP-1 receptor agonists are no longer just diabetes drugs

Overcoming access challenges with transitional assistance The market access environment for new launch products has become progressively restrictive with payers enforcing more prior authorizations, step edits, and blocks than ever before

GLP-1 receptor agonists are delivering benefits beyond weight loss

Medication Ships

The 3 scenarios: Video 1 Neutral pH (7.4): semaglutide dissolves cleanly

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.